Skip to main content
Top
Published in: Supportive Care in Cancer 1/2015

01-01-2015 | Original Article

Clinical implications of malnutrition in childhood cancer patients—infections and mortality

Authors: E. A. H. Loeffen, A. Brinksma, K. G. E. Miedema, G. H. de Bock, W. J. E. Tissing

Published in: Supportive Care in Cancer | Issue 1/2015

Login to get access

Abstract

Purpose

In childhood cancer patients, malnutrition has been proposed to increase infection rates and reduce survival. We investigated whether malnutrition at diagnosis and during treatment and weight loss during treatment are prognostic factors for infection rates and survival, within a heterogeneous childhood cancer population.

Methods

From two previous studies, all children ≤18 years of age diagnosed with cancer between October 2004 and October 2011 were included in this study. Data regarding BMI, infections, and survival were retrieved. Patients with a BMI z-score lower than −2.0 were classified as malnourished. Weight loss more than 5 % was considered relevant.

Results

Two hundred sixty-nine childhood cancer patients were included in this study. At diagnosis, 5.2 % of all patients were malnourished. These patients showed worse survival than those who were well nourished (hazard ratio (HR) = 3.63, 95 % confidence interval (CI) = 1.52–8.70, p = 0.004). Malnourishment at 3 months after diagnosis (3.3 % of all patients) also showed worse survival (HR = 6.34, 95 % CI = 2.42–16.65, p < 0.001). Weight loss of more than 5 % in the first 3 months after diagnosis was related to increased occurrence of febrile neutropenic episodes with bacteremia in the first year after diagnosis (odds ratio (OR) = 3.05, 95 % CI = 1.27–7.30, p = 0.012).

Conclusion

We found that malnourishment in the initial phase of therapy is associated with worse survival in childhood cancer patients. In addition, we found for the first time that weight loss during treatment is associated with increased presence of febrile neutropenic episodes with bacteremia. This underlines the importance of optimal feeding designs in childhood cancer patients.
Appendix
Available only for authorised users
Literature
2.
go back to reference Freycon F, Trombert-Paviot B, Casagranda L, Bertrand Y, Plantaz D, Marec-Berard P (2008) Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhone-Alpes region in France (ARCERRA). Pediatr Blood Cancer 50(6):1213–1220PubMedCrossRef Freycon F, Trombert-Paviot B, Casagranda L, Bertrand Y, Plantaz D, Marec-Berard P (2008) Trends in treatment-related deaths (TRDs) in childhood cancer and leukemia over time: a follow-up of patients included in the childhood cancer registry of the Rhone-Alpes region in France (ARCERRA). Pediatr Blood Cancer 50(6):1213–1220PubMedCrossRef
3.
4.
go back to reference Lange BJ, Gerbing RB, Feusner J et al (2005) Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 293(2):203–211PubMedCrossRef Lange BJ, Gerbing RB, Feusner J et al (2005) Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 293(2):203–211PubMedCrossRef
5.
go back to reference Cunningham-Rundles S, McNeeley DF, Moon A (2005) Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 115(6):1119–1129PubMedCrossRef Cunningham-Rundles S, McNeeley DF, Moon A (2005) Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 115(6):1119–1129PubMedCrossRef
7.
go back to reference Lobato-Mendizabal E, Lopez-Martinez B, Ruiz-Arguelles GJ (2003) A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia. Rev Invest Clin 55(1):31–35PubMed Lobato-Mendizabal E, Lopez-Martinez B, Ruiz-Arguelles GJ (2003) A critical review of the prognostic value of the nutritional status at diagnosis in the outcome of therapy of children with acute lymphoblastic leukemia. Rev Invest Clin 55(1):31–35PubMed
8.
go back to reference Butturini AM, Dorey FJ, Lange BJ et al (2007) Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 25(15):2063–2069PubMedCrossRef Butturini AM, Dorey FJ, Lange BJ et al (2007) Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 25(15):2063–2069PubMedCrossRef
9.
go back to reference Murry DJ, Riva L, Poplack DG (1998) Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 11:48–51PubMedCrossRef Murry DJ, Riva L, Poplack DG (1998) Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 11:48–51PubMedCrossRef
10.
go back to reference Brinksma A, Huizinga G, Sulkers E, Kamps W, Roodbol P, Tissing W (2012) Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol 83(2):249–275PubMedCrossRef Brinksma A, Huizinga G, Sulkers E, Kamps W, Roodbol P, Tissing W (2012) Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol 83(2):249–275PubMedCrossRef
11.
go back to reference Oude Nijhuis C, Kamps WA, Daenen SM et al (2005) Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 23(30):7437–7444PubMedCrossRef Oude Nijhuis C, Kamps WA, Daenen SM et al (2005) Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 23(30):7437–7444PubMedCrossRef
12.
go back to reference Miedema KG, de Bont ES, Oude Nijhuis CS, van Vliet D, Kamps WA, Tissing WJ (2011) Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia. J Clin Oncol 29(7):e182–e184PubMedCrossRef Miedema KG, de Bont ES, Oude Nijhuis CS, van Vliet D, Kamps WA, Tissing WJ (2011) Validation of a new risk assessment model for predicting adverse events in children with fever and chemotherapy-induced neutropenia. J Clin Oncol 29(7):e182–e184PubMedCrossRef
13.
go back to reference Stratton RJ, Green CJ, Elia M (2003) Disease related malnutrition, an evidence based approach to treatment, 1st edn. CABI Publishing, Wallingford Stratton RJ, Green CJ, Elia M (2003) Disease related malnutrition, an evidence based approach to treatment, 1st edn. CABI Publishing, Wallingford
14.
go back to reference Kazak AE, Hocking MC, Ittenbach RF et al (2012) A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer 59(1):96–99PubMedCentralPubMedCrossRef Kazak AE, Hocking MC, Ittenbach RF et al (2012) A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer 59(1):96–99PubMedCentralPubMedCrossRef
15.
go back to reference Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457–481CrossRef Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53(282):457–481CrossRef
16.
go back to reference Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170PubMed Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163–170PubMed
17.
go back to reference Cox D (1972) Regression models and life tables. J R Stat Soc 34(2):187–220 Cox D (1972) Regression models and life tables. J R Stat Soc 34(2):187–220
18.
go back to reference Burke ME, Lyden ER, Meza JL, Ladas EJ, Dasgupta R, Wiegner EA, Arndt CA (2013) Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer 60(5):748–753PubMedCrossRef Burke ME, Lyden ER, Meza JL, Ladas EJ, Dasgupta R, Wiegner EA, Arndt CA (2013) Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children’s Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer 60(5):748–753PubMedCrossRef
19.
go back to reference Inaba H, Surprise HC, Pounds S, et al (2012) Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer Inaba H, Surprise HC, Pounds S, et al (2012) Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer
20.
go back to reference Reilly JJ (1998) Assessment of body composition in infants and children. Nutrition 14(10):821–825PubMedCrossRef Reilly JJ (1998) Assessment of body composition in infants and children. Nutrition 14(10):821–825PubMedCrossRef
21.
go back to reference Sala A, Rossi E, Antillon F et al (2012) Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer 48(2):243–252PubMedCrossRef Sala A, Rossi E, Antillon F et al (2012) Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer 48(2):243–252PubMedCrossRef
22.
go back to reference Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P et al (2011) Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 80(1):114–144PubMedCrossRef Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P et al (2011) Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol 80(1):114–144PubMedCrossRef
Metadata
Title
Clinical implications of malnutrition in childhood cancer patients—infections and mortality
Authors
E. A. H. Loeffen
A. Brinksma
K. G. E. Miedema
G. H. de Bock
W. J. E. Tissing
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2350-9

Other articles of this Issue 1/2015

Supportive Care in Cancer 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine